Last updated on: 10/31/2011 | Author:

Serge Sevy, MD, MBA Biography

Adjunct Associate Professor of Clinical Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“[A]lthough cannabis use precedes the onset of illness in most patients, there was no significant association between onset of illness and CUD (cannabis use disorders) that was not accounted by demographic and clinical variables. Previous studies implicating CUD in the onset of schizophrenia may need to more comprehensively assess the relationship between CUD and schizophrenia, and take into account additional variables that we found associated with CUD.”

“Are Cannabis Use Disorders Associated with an Earlier Age at Onset of Psychosis? A Study in First Episode Schizophrenia,” Schizophrenia Research, July 2010

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Adjunct Associate Professor, Department of Clinical Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, 2000-present
  • Research Psychiatrist, Zucker Hillside Hospital (Glen Oaks, NY), 2000-present
  • Residency, Psychiatry, Mount Sinai Medical Center (New York, NY), 1993-1997
  • Research Fellow, Biological Psychiatry and Psychopharmacology, Albert Einstein College of Medicine, 1987-1989
  • Residency, Neuro-Psychiatry, Erasme University Hospital Brussels (Belgium), 1983-1987
  • MBA, Mount Sinai School of Medicine, 1990
  • MD, Universit√© Libre de Bruxelles (Belgium), 1983
  • None found